ACAD · Company research
Acadia Pharmaceuticals Inc. (ACAD): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 19.74 | $3,571,560,080 | 3289348080.00 | 8.094890510948904 | — | — | 13.3236343830904791 | 2.8616756485634574 | 124.14613229517883832936 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.